InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: tradero post# 226268

Wednesday, 07/15/2015 6:20:56 AM

Wednesday, July 15, 2015 6:20:56 AM

Post# of 345967
one thing to remember is SK said that the IDMC is constantly, ongoing ??? not sure which word he used but SK certainly did not say that IDMC will "only" look once at 1st interim and 2nd at 2nd interim.

Its most likely they are watching an entire slew of parameters ( on a rolling basis)... "plus" certain key parameters at 1st look in... at 33% and certain key parameters at 2nd look in

I think the IDMC is watching more closely at certain parameters than we are led on to believe

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News